Vickers Vantage Corp. I VCKAW NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • SG • USD

Il y a eu 39 transactions d'initiés récentes enregistrées pour Vickers Vantage Corp. I (VCKAW), dont 19 achats et 13 ventes. Le total des achats d'initiés s'élève à $1.93M et le total des ventes d'initiés à $140.3M.

Les initiés notables ayant une activité récente comprennent Shah Jaisim, Ji Henry, Wu Yue Alexander. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — VCKAW

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-10-04	Shah Jaisim	See Remarks	Attribution de RSU	200,000	$1.41	$282K	200,000
2023-10-04	Ji Henry	Executive Chairperson	Attribution de RSU	200,000	$1.41	$282K	200,000
2023-10-04	Wu Yue Alexander	Director	Attribution de RSU	250,000	$1.41	$352.5K	250,000
2023-10-04	Ma Stephen Hoi	Chief Financial Officer	Attribution de RSU	150,000	$1.41	$211.5K	150,000
2023-10-04	Chun Jay	Director	Attribution de RSU	250,000	$1.41	$352.5K	250,000
2023-09-22	Wu Yue Alexander	Director	Cession	404,098	$1.73	$699.09K	-
2023-09-22	Ma Stephen Hoi	Chief Financial Officer	Cession	294,106	$8.08	$2.38M	-
2023-09-22	Chun Jay	Director	Cession	-	-	-	45,000
2023-09-22	Sclx Stock Acquisition Jv Llc	10 Percent Owner	Cession	490,617	$11.50	$5.64M	-
2023-09-22	Ji Henry	Executive Chairperson	Cession	9,000,000	$8.08	$72.72M	-
2023-09-21	Sorrento Therapeutics, Inc.	10 Percent Owner	Vente Informative	4,490,617	$11.50	$51.64M	-
2023-03-17	Ji Henry	Executive Chairperson	Autre (Achat)	2,730	$8.60	$23.48K	2,730
2023-01-19	Sorrento Therapeutics, Inc.	Director	Autre (Vente)	73,740,795	-	-	61,985,795
2023-01-17	Shah Jaisim	See Remarks	Attribution de RSU	1,700,000	-	-	1,700,000
2023-01-17	Czerepak Elizabeth	See Remarks	Attribution de RSU	350,000	-	-	350,000
2023-01-17	Thompson Tommy G	Director	Attribution de RSU	250,000	-	-	250,000
2023-01-17	Ji Henry	Executive Chairperson	Attribution de RSU	9,000,000	-	-	9,000,000
2023-01-17	Followwill Dorman	Director	Attribution de RSU	250,000	-	-	250,000
2023-01-17	Lemus David	Director	Attribution de RSU	250,000	-	-	250,000
2023-01-17	Hamill Laura	Director	Attribution de RSU	250,000	-	-	250,000
2023-01-17	Lee Tien-li	Director	Attribution de RSU	250,000	-	-	250,000
2022-12-02	Sorrento Therapeutics, Inc.	Director	Achat Informatif	224,841	$0.35	$78.85K	4,490,617
2022-11-25	Sorrento Therapeutics, Inc.	Director	Achat Informatif	46,172	$0.44	$20.2K	4,265,776
2022-11-23	Sorrento Therapeutics, Inc.	Director	Achat Informatif	442,829	$0.40	$175.67K	4,219,604
2022-11-22	Sorrento Therapeutics, Inc.	Director	Achat Informatif	672,775	$0.23	$152.05K	3,776,775
2022-11-10	Sorrento Therapeutics, Inc.	Director	Cession	-	-	-	29,057,097
2022-11-10	Sorrento Therapeutics, Inc.	Director	Autre (Achat)	2,796,704	-	-	2,796,704
2022-11-10	Shah Jaisim	See Remarks	Cession	1,568,438	$1.73	$2.71M	-
2022-11-10	Czerepak Elizabeth	See Remarks	Cession	404,098	$1.73	$699.09K	-
2022-11-10	Thompson Tommy G	Director	Inconnu	-	-	-	-
2022-11-10	Ji Henry	Executive Chairperson	Cession	1,799,470	$1.73	$3.11M	-
2022-11-10	Followwill Dorman	Director	Inconnu	-	-	-	-
2022-11-10	Lemus David	Director	Inconnu	-	-	-	-
2022-11-10	Kaji Suneel G	Director	Inconnu	-	-	-	-
2022-11-10	Hamill Laura	Director	Inconnu	-	-	-	-
2022-11-10	Myint Steve	Director	Inconnu	-	-	-	-
2022-11-10	Woo Pei Wei	Director	Inconnu	-	-	-	-
2022-11-10	Vickers Venture Fund Vi Pte Ltd	Director	Autre (Vente)	578,160	-	-	99,000
2022-11-10	Lee Tien-li	Director	Cession	404,098	$1.73	$699.09K	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration